Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Harmony Gold Mining Co. (HMY) vs Repligen Corporation Common Stock (RGEN) Price & Performance

Harmony Gold Mining Co.Trade
Repligen Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Harmony Gold Mining Co. vs Repligen Corporation Common Stock — how do they compare? Harmony Gold Mining Co. trades at $16.84 (market cap $10.25B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.31B). The key difference: Harmony Gold Mining Co. and Repligen Corporation Common Stock are close in size by market cap, and Harmony Gold Mining Co. pays a 4.79% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Harmony Gold Mining Co. for 45 Days and Repligen Corporation Common Stock for 0 Days on average.

HMYRGEN
Market Cap
$10.25B$11.31B
Volume
3,439,0621,216,919
Sector
Basic MaterialsHealth
52-Week High
$26.04$194.57
52-Week Low
$13.32$102.87
Typical Hold Time
45 Days0 Days
Enterprise Value
$10.30B$11.20B
Dividend Yield
4.79%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Harmony Gold Mining Co.

Harmony Gold Mining (HMY) trades at $16.71, up 0.18% on the day, with a bearish technical signal despite strong fundamentals. The company reported record fiscal 2026 results with revenue reaching $99.2B and net income of $29.3B, driven by higher gold prices and copper expansion. Valuation metrics remain attractive with P/E of 5.96 and EV/EBITDA of 3.64, while profitability metrics show robust ROE of 46.23% and net margin of 29.57%.

HMY presents a compelling value opportunity with strong cash flow generation and strategic copper diversification, though technical weakness and mixed analyst sentiment (70% hold rating) suggest near-term caution. Key risks include commodity price volatility and execution of copper expansion plans, while the current valuation discount to historical levels offers potential upside for patient investors.

Repligen Corporation Common Stock

RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.

Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HMY
100% Buy0% Sell
Avg holding period · 45 Days
RGEN
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Harmony Gold Mining Co.

Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.

Read more on HMY →

About Repligen Corporation Common Stock

Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.

Read more on RGEN →